The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Mechanisms of Sympathetic Activation in Obesity-Related Hypertension
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“First, cardiac norepinephrine spillover is decreased in obese normotensives and is only marginally increased in obese hypertensives59,60–61.”
From The Sympathetic Nervous System Alterations in Human Hypertension (2015) · cites this paper as [60]
In the citing paper
“Most notably, elevated sympathetic activity in obesity often occurs in the absence of hypertension3,59,60–61.”
From The Sympathetic Nervous System Alterations in Human Hypertension (2015) · cites this paper as [61]
In the citing paper
“Sophisticated studies using microneurography and/or radiolabeled norepinephrine spillover have unequivocally supported Landsberg’s concept of sympathetic overactivity in most human obesity3,60–61,64.”
From The Sympathetic Nervous System Alterations in Human Hypertension (2015) · cites this paper as [61]
In the citing paper
“First, cardiac norepinephrine spillover is decreased in obese normotensives and is only marginally increased in obese hypertensives59,60–61.”
From The Sympathetic Nervous System Alterations in Human Hypertension (2015) · cites this paper as [61]
In the citing paper
“Second, in obese humans renal norepinephrine spillover is not significantly higher in hypertensive than it is in normotensive subjects60–61.”
From The Sympathetic Nervous System Alterations in Human Hypertension (2015) · cites this paper as [60]
In the citing paper
“This contrasts with marked elevation in cardiac norepinephrine spillover in lean hypertensives60.”
From The Sympathetic Nervous System Alterations in Human Hypertension (2015) · cites this paper as [60]
In the citing paper
“Most notably, elevated sympathetic activity in obesity often occurs in the absence of hypertension3,59,60–61.”
From The Sympathetic Nervous System Alterations in Human Hypertension (2015) · cites this paper as [60]
In the citing paper
“Sophisticated studies using microneurography and/or radiolabeled norepinephrine spillover have unequivocally supported Landsberg’s concept of sympathetic overactivity in most human obesity3,60–61,64.”
From The Sympathetic Nervous System Alterations in Human Hypertension (2015) · cites this paper as [60]
Citations
Cites
Dahlöf, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G., de Faire, U., Fyhrquist, F., Ibsen, H., Kristiansson, K., Lederballe-Pedersen, O., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08089-3 · Cited by 5,407
Maffei, M., Halaas, J., Ravussin, E., Pratley, R. E., Lee, G. H., Zhang, Y., Fei, H., Kim, S., Lallone, R., Ranganathan, S., et al. (1995) · Nature Medicine · doi:10.1038/nm1195-1155 · Cited by 3,725
Campfield, L. A., Smith, F. J., Guisez, Y., Devos, R., & Burn, P. (1995) · Science · doi:10.1126/science.7624778 · Cited by 3,243
Congenital leptin deficiency is associated with severe early-onset obesity in humans
Montague, C. T., Farooqi, I. S., Whitehead, J. P., Soos, M. A., Rau, H., Wareham, N. J., Sewter, C. P., Digby, J. E., Mohammed, S. N., Hurst, J. A., et al. (1997) · Nature · doi:10.1038/43185 · Cited by 2,936
Sympathetic neural mechanisms in obstructive sleep apnea.
Somers, V. K., Dyken, M. E., Clary, M. P., & Abboud, F. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118235 · Cited by 2,527
Hyperinsulinemia. A link between hypertension obesity and glucose intolerance.
Modan, M., Halkin, H., Almog, S., Lusky, A., Eshkol, A., Shefi, M., Shitrit, A., & Fuchs, Z. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111776 · Cited by 1,465
Obesity-related glomerulopathy: An emerging epidemic
Kambham, N., Markowitz, G. S., Valeri, A. M., Lin, J., & D’Agati, V. D. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.0590041498.x · Cited by 1,288
Sympathetic Overactivity in Patients with Chronic Renal Failure
Converse, R. L., Jacobsen, T. N., Toto, R. D., Jost, C. M. T., Cosentino, F., Fouad-Tarazi, F., & Victor, R. G. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212313272704 · Cited by 1,132
Chronic stress at work and the metabolic syndrome: prospective study
Chandola, T., Brunner, E., & Marmot, M. (2006) · BMJ · doi:10.1136/bmj.38693.435301.80 · Cited by 1,075
Rapid Rewiring of Arcuate Nucleus Feeding Circuits by Leptin
Pinto, S., Roseberry, A. G., Liu, H., Diano, S., Shanabrough, M., Cai, X., Friedman, J. M., & Horvath, T. L. (2004) · Science · doi:10.1126/science.1089459 · Cited by 987
Research works printed but not linked: 12
- 10.1161/circ.96.10.3423 · DOI
- 10.1161/hyp.25.4.893 · DOI
- 10.1161/hyp.31.1.64 · DOI
- 10.1161/hyp.25.4.560 · DOI
- Esler M. Looking at the sympathetic nervous system as a primary source. In: Zanchetti A Robertson JIS Birkenhager WH ed. Handbook of Hypertension: Hypertension Research in the Twentieth Century. Amsterdam the Netherlands: Elsevier; 2004; 81–103.
- Grassi G, Dell Oro R, Quarti-Trevano F, Scopelliti F, Seravalle G, Paleari F, Gamba PL, Mancia G. Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome. Diabetologia. 2005; 48: 1349–1356.
- 10.1161/circ.98.8.772 · DOI
- 10.1161/hyp.33.1.537 · DOI
- 10.1161/hyp.30.3.619 · DOI
- 10.1161/hyp.35.5.1135 · DOI
- Dickinson CJ. Neurogenic Hypertension. Oxford United Kingdom: Blackwell Scientific; 1965
- 10.1161/hyp.30.1.140 · DOI
Cited by
Sorted by citations
Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis
D’Agati, V. D., Chagnac, A., de Vries, A. P. J., Levi, M., Porrini, E., Herman‐Edelstein, M., & Praga, M. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.75 · Cited by 735
The Sympathetic Nervous System Alterations in Human Hypertension
Grassi, G., Mark, A., & Esler, M. (2015) · Circulation Research · doi:10.1161/circresaha.116.303604 · Cited by 616
Self-citationMahfoud, F., Schlaich, M. P., Kindermann, I., Ukena, C., Cremers, B., Brandt, M. C., Hoppe, U. C., Vonend, O., Rump, L. C., Sobotka, P. A., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.991869 · Cited by 577
Self-citationThe pathophysiology of hypertension in patients with obesity
DeMarco, V. G., Aroor, A. R., & Sowers, J. R. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.44 · Cited by 545
The human sympathetic nervous system: its relevance in hypertension and heart failure
Parati, G., & Esler, M. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs041 · Cited by 538
Self-citationObesity-induced Hypertension: Role of Sympathetic Nervous System, Leptin, and Melanocortins
Hall, J. E., da Silva, A. A., do Carmo, J. M., Dubinion, J., Hamza, S., Munusamy, S., Smith, G., & Stec, D. E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.113175 · Cited by 528
Hypothalamic inflammation in obesity and metabolic disease
Jais, A., & Brüning, J. C. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88878 · Cited by 474
Montano, N., Porta, A., Cogliati, C. B., Costantino, G., Tobaldini, E., Casali, K. R., & Iellamo, F. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.07.006 · Cited by 471
The sympathetic nervous system and the metabolic syndrome
Mancia, G., Bousquet, P., Elghozi, J. L., Esler, M., Grassi, G., Julius, S., Reid, J., & Van Zwieten, P. A. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e328048d004 · Cited by 385
Self-citationLeptin Mediates the Increase in Blood Pressure Associated with Obesity
Simonds, S. E., Pryor, J. T., Ravussin, É., Greenway, F. L., Dileone, R., Allen, A. M., Bassi, J. K., Elmquist, J. K., Keogh, J. M., Henning, E., et al. (2014) · Cell · doi:10.1016/j.cell.2014.10.058 · Cited by 352
Lambert, G. W., Straznicky, N. E., Lambert, É., Dixon, J. B., & Schlaich, M. P. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.02.002 · Cited by 352
Self-citationDietary Therapy in Hypertension
Sacks, F. M., & Campos, H. (2010) · New England Journal of Medicine · doi:10.1056/nejmct0911013 · Cited by 250
Esler, M. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00832.2009 · Cited by 245
Self-citationThe Role of the Autonomic Nervous System in the Pathophysiology of Obesity
Guarino, D., Nannipieri, M., Iervasi, G., Taddei, S., & Bruno, R. M. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00665 · Cited by 259
Obesity and adipokines: effects on sympathetic overactivity
Smith, M. M., & Minson, C. T. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2011.221036 · Cited by 245
Hypertension: Physiology and Pathophysiology
Hall, J. E., Granger, J. P., do Carmo, J. M., da Silva, A. A., Dubinion, J., George, E., Hamza, S., Speed, J., & Hall, M. E. (2012) · Comprehensive Physiology · doi:10.1002/cphy.c110058 · Cited by 232
Ying, Z., Xu, X., Bai, Y., Zhong, J., Chen, M., Liang, Y., Zhao, J., Liu, D., Morishita, M., Sun, Q., et al. (2013) · Environmental Health Perspectives · doi:10.1289/ehp.1307151 · Cited by 235
Sympathetic Nervous System and Blood Pressure in Humans
Joyner, M. J., Charkoudian, N., & Wallin, B. G. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.140186 · Cited by 221
Ribeiro, M. J., Sacramento, J. F., González, C., Guarino, M. P., Monteiro, E. C., & Conde, S. V. (2013) · Diabetes · doi:10.2337/db12-1463 · Cited by 221
Lambert, E., Sari, C. I., Dawood, T., Nguyen, J., McGrane, M., Eikelis, N., Chopra, R., Wong, C., Chatzivlastou, K., Head, G., et al. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.155663 · Cited by 209
Self-citationYadav, R. L., Yadav, P. K., Yadav, L. K., Agrawal, K., Sah, S. K., & Islam, M. N. (2017) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s123935 · Cited by 216
Metabolic syndrome: a sympathetic disease?
Schlaich, M., Straznicky, N., Lambert, E., & Lambert, G. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70033-6 · Cited by 171
Self-citationCirculating angiotensin II and dietary salt: Converging signals for neurogenic hypertension
Osborn, J. W., Fink, G. D., Sved, A. F., Toney, G. M., & Raizada, M. K. (2007) · Current Hypertension Reports · doi:10.1007/s11906-007-0041-3 · Cited by 164
Agarwal, D., Welsch, M. A., Keller, J. N., & Francis, J. (2011) · Basic Research in Cardiology · doi:10.1007/s00395-011-0231-7 · Cited by 164
The additive blood pressure lowering effects of exercise intensity on post‐exercise hypotension
Eicher, J. D., Maresh, C. M., Tsongalis, G. J., Thompson, P. D., & Pescatello, L. S. (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.06.005 · Cited by 151
Arterial Chemoreceptors and Sympathetic Nerve Activity
Schultz, H. D., Li, Y. L., & Ding, Y. (2007) · Hypertension · doi:10.1161/hypertensionaha.106.076083 · Cited by 149
Characterization of autonomic symptom burden in long COVID: A global survey of 2,314 adults
Larsen, N. W., Stiles, L. E., Shaik, R., Schneider, L. D., Muppidi, S., Tsui, C. T., Geng, L. N., Bonilla, H. F., & Miglis, M. G. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.1012668 · Cited by 152
Autonomic Contribution to Blood Pressure and Metabolism in Obesity
Shibao, C., Gamboa, A., Diedrich, A., Ertl, A. C., Chen, K. Y., Byrne, D. W., Farley, G., Paranjape, S. Y., Davis, S. N., & Biaggioni, I. (2007) · Hypertension · doi:10.1161/01.hyp.0000251679.87348.05 · Cited by 147
Shigetoh, Y., Adachi, H., Yamagishi, S., Enomoto, M., Fukami, A., Otsuka, M., Kumagae, S., Furuki, K., Nanjo, Y., & Imaizumi, T. (2009) · American Journal of Hypertension · doi:10.1038/ajh.2008.331 · Cited by 146
Esler, M., Lambert, E., & Schlaich, M. (2010) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00182.2010 · Cited by 141
Self-citationPark, D., Lee, J.-H., & Han, S. W. (2017) · Medicine · doi:10.1097/md.0000000000008769 · Cited by 138
Pathophysiology of Resistant Hypertension: The Role of Sympathetic Nervous System
Tsioufis, C. P., Kordalis, A., Flessas, D., Anastasopoulos, I., Tsiachris, D., Papademetriou, V., & Stefanadis, C. (2011) · International Journal of Hypertension · doi:10.4061/2011/642416 · Cited by 140
Nagae, A., Fujita, M., Kawarazaki, H., Matsui, H., Ando, K., & Fujita, T. (2009) · Circulation · doi:10.1161/circulationaha.108.824730 · Cited by 135
Systemic and Renal-Specific Sympathoinhibition in Obesity Hypertension
Lohmeier, T. E., Iliescu, R., Liu, B., Henegar, J. R., Maric-Bilkan, C., & Irwin, E. D. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.185074 · Cited by 130
The Baroreflex as a Long-Term Controller of Arterial Pressure
Lohmeier, T. E., & Iliescu, R. (2015) · Physiology · doi:10.1152/physiol.00035.2014 · Cited by 126
Leptin as a Mediator of Obesity-Induced Hypertension
Bell, B., & Rahmouni, K. (2016) · Current Obesity Reports · doi:10.1007/s13679-016-0231-x · Cited by 128
Mechanism of Salt-Sensitive Hypertension: Focus on Adrenal and Sympathetic Nervous Systems
Fujita, T. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013121258 · Cited by 124
An Overview of the Role of Adipokines in Cardiometabolic Diseases
Farkhondeh, T., Llorens, S., Pourbagher‐Shahri, A. M., Ashrafizadeh, M., Talebi, M., Shakibaei, M., & Samarghandian, S. (2020) · Molecules · doi:10.3390/molecules25215218 · Cited by 127
Gender differences in sympathetic nervous activity: influence of body mass and blood pressure
Lambert, É., Straznicky, N. E., Eikelis, N., Esler, M., Dawood, T., Masuo, K., Schlaich, M. P., & Lambert, G. W. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3281053af4 · Cited by 123
Self-citationIs the brain the essential in hypertension?
Jennings, J. R., & Zanstra, Y. J. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.04.072 · Cited by 121
Excessive Sympathetic Activation in Heart Failure With Obesity and Metabolic Syndrome
Grassi, G. M., Seravalle, G., Quarti‐Trevano, F., Scopelliti, F., Dell’Oro, R., Bolla, G. B., & Mancia, G. (2007) · Hypertension · doi:10.1161/01.hyp.0000255983.32896.b9 · Cited by 121
Sympathetic Nervous System Contributions to Hypertension: Updates and Therapeutic Relevance
DeLalio, L. J., Sved, A. F., & Stocker, S. D. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.03.003 · Cited by 135
Ward, K. R., Bardgett, J. F., Wolfgang, L., & Stocker, S. D. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.160671 · Cited by 118
Prolonged Activation of the Baroreflex Abolishes Obesity-Induced Hypertension
Lohmeier, T. E., Dwyer, T. M., Irwin, E. D., Rossing, M. A., & Kieval, R. S. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.087874 · Cited by 118
Lambert, E. A., Teede, H., Sari, C. I., Jona, E., Shorakae, S., Woodington, K., Hemmes, R., Eikelis, N., Straznicky, N. E., De Courten, B., et al. (2015) · Clinical Endocrinology · doi:10.1111/cen.12803 · Cited by 112
Self-citationIntra-abdominal Adiposity and Individual Components of the Metabolic Syndrome in Adolescence
Syme, C. A., Abrahamowicz, M., Leonard, G. T., Perron, M., Pitiot, A., Qiu, X., Richer, L., Totman, J. J., Veillette, S., Xiao, Y., et al. (2008) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.162.5.453 · Cited by 114
Straznicky, N. E., Lambert, G. W., Masuo, K., Dawood, T., Eikelis, N., Nestel, P. J., McGrane, M. T., Mariani, J. A., Socratous, F., Chopra, R., et al. (2008) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26299 · Cited by 114
Self-citationImproving obesity and blood pressure
Tanaka, M. (2019) · Hypertension Research · doi:10.1038/s41440-019-0348-x · Cited by 113
Sympathetic nervous system as a target for aging and obesity-related cardiovascular diseases
Balasubramanian, P., Hall, D., & Subramanian, M. (2018) · GeroScience · doi:10.1007/s11357-018-0048-5 · Cited by 111
The role of sympathetic nervous activity in renal injury and end-stage renal disease
Masuo, K., Lambert, G. W., Esler, M., Rakugi, H., Ogihara, T., & Schlaich, M. P. (2010) · Hypertension Research · doi:10.1038/hr.2010.35 · Cited by 107
Self-citationPrevalence of High Blood Pressure in 122,053 Adolescents: A Systematic Review and Meta-Regression
Moraes, A. D. D., Lacerda, M., Moreno, L., Horta, B., & Carvalho, H. (2014) · Medicine · doi:10.1097/md.0000000000000232 · Cited by 106
Chronic Lowering of Blood Pressure by Carotid Baroreflex Activation
Lohmeier, T. E., & Iliescu, R. (2011) · Hypertension · doi:10.1161/hypertensionaha.108.119859 · Cited by 100
Hirooka, Y. (2011) · Hypertension Research · doi:10.1038/hr.2011.14 · Cited by 99
Management of Obesity in Adults with CKD
Friedman, A. N., Kaplan, L. M., le Roux, C. W., & Schauer, P. R. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020101472 · Cited by 99
Galletti, F., D’Elia, L., Barba, G., Siani, A., Cappuccio, F. P., Farinaro, E., Iacone, R., Russo, O., Palma, D. D., Ippolito, R., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1280 · Cited by 94
Novel Invasive and Noninvasive Cardiac-Specific Biomarkers in Obesity and Cardiovascular Diseases
Parsanathan, R., & Jain, S. K. (2019) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2019.0073 · Cited by 98
The adrenal gland in stress – Adaptation on a cellular level
Berger, I., Werdermann, M., Bornstein, S. R., & Steenblock, C. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.04.006 · Cited by 102
Vascular endothelial ageing, heartbeat after heartbeat
Thorin, É., & Thorin‐Trescases, N. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp236 · Cited by 91
Hammoud, S. H., AlZaim, I., Al-Dhaheri, Y., Eid, A. H., & El-Yazbi, A. F. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.707126 · Cited by 87
Carotid body, insulin, and metabolic diseases: unraveling the links
Conde, S. V., Sacramento, J. F., Guarino, M. P., González, C., Obeso, A., Diogo, L. N., Monteiro, E. C., & Ribeiro, M. J. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00418 · Cited by 89
Mechanisms of endothelial dysfunction in obesity-associated hypertension
Lobato, N. S., Filgueira, F. P., Akamine, E. H., Tostes, R. C., de Carvalho, M. H. C., & Fortes, Z. B. (2012) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2012007500058 · Cited by 84
Schlaich, M. P., Hering, D., Sobotka, P. A., Krum, H., Lambert, G. W., Lambert, É., & Esler, M. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00010 · Cited by 81
Self-citationVisaria, A., & Setoguchi, S. (2023) · PLoS ONE · doi:10.1371/journal.pone.0287218 · Cited by 97
Bruder-Nascimento, T. B., Ekeledo, O. J., Anderson, R., Le, H. B. Q., & de Chantemèle, E. J. B. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00032 · Cited by 82
Sympathetic Nervous System Activation and Its Modulation: Role in Atrial Fibrillation
Carnagarin, R., Kiuchi, M. G., Ho, J. K., Matthews, V. B., & Schlaich, M. P. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.01058 · Cited by 81
Aghamohammadzadeh, R., & Heagerty, A. M. (2012) · Annals of Medicine · doi:10.3109/07853890.2012.663928 · Cited by 79
Licht, C. M. M., Penninx, B. W. J. H., & de Geus, E. J. C. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.107 · Cited by 80
Neurons of the Rostral Ventrolateral Medulla Contribute to Obesity-Induced Hypertension in Rats
Stocker, S. D., Meador, R., & Adams, J. M. (2006) · Hypertension · doi:10.1161/01.hyp.0000254828.71253.dc · Cited by 77
Martelli, D., & Brooks, V. L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032684 · Cited by 79
Noronha, S. I. S. R., Campos, G. V., de Abreu, A. R. R., de Souza, A. M. A., Chianca, D. A., & de Menezes, R. C. A. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.08.042 · Cited by 73
Sex, the brain and hypertension: brain oestrogen receptors and high blood pressure risk factors
Hay, M. (2015) · Clinical Science · doi:10.1042/cs20150654 · Cited by 75
Device-Based Neuromodulation for Resistant Hypertension Therapy
Lohmeier, T. E., & Hall, J. E. (2019) · Circulation Research · doi:10.1161/circresaha.118.313221 · Cited by 74
Excess dietary salt intake alters the excitability of central sympathetic networks
Stocker, S. D., Madden, C. J., & Sved, A. F. (2010) · Physiology & Behavior · doi:10.1016/j.physbeh.2010.04.024 · Cited by 69
Bardgett, M. E., McCarthy, J. J., & Stocker, S. D. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.146605 · Cited by 70
Seravalle, G., Lonati, L. M., Buzzi, S., Cairo, M., Trevano, F. Q., Dell’Oro, R., Facchetti, R., Mancia, G., & Grassi, G. M. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000567 · Cited by 68
Sleep Apnea, Aldosterone, and Resistant Hypertension
Pimenta, E., Calhoun, D. A., & Oparil, S. (2009) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2008.02.004 · Cited by 68
Morikawa, M., Okazaki, K., Masuki, S., Kamijo, Y., Yamazaki, T., Gen-no, H., & Nosé, H. (2009) · British Journal of Sports Medicine · doi:10.1136/bjsm.2009.064816 · Cited by 68
Adrenal medullary dysfunction as a feature of obesity
Reimann, M., Qin, N., Gruber, M., Bornstein, S. R., Kirschbaum, C., Ziemssen, T., & Eisenhofer, G. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.36 · Cited by 64
Oxidative stress in the brain causes hypertension via sympathoexcitation
Kishi, T., & Hirooka, Y. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00335 · Cited by 63
Rafiq, K., Fujisawa, Y., Sherajee, S. J., Rahman, A., Sufiun, A., Kobori, H., Koepsell, H., Mogi, M., Horiuchi, M., & Nishiyama, A. (2015) · Diabetologia · doi:10.1007/s00125-015-3771-9 · Cited by 63
Altered Cardiac Autonomic Function May Precede Insulin Resistance in Metabolic Syndrome
Chang, C., Yang, Y., Lu, F., Lin, T., Chen, J., Yeh, T. L., Wu, C., & Wu, J. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.07.031 · Cited by 62
The Sympathetic Nervous System in Obesity Hypertension
Lohmeier, T. E., & Iliescu, R. (2013) · Current Hypertension Reports · doi:10.1007/s11906-013-0356-1 · Cited by 62
“This possibility is supported by the demonstration of increased renal norepinephrine (NE) spillover in both the early prehypertensive and advanced stages of hypertension in obese human subjects [1, 18, 19].”
Obesity-induced increases in sympathetic nerve activity: Sex matters
Brooks, V. L., Shi, Z., Holwerda, S. W., & Fadel, P. J. (2014) · Autonomic Neuroscience · doi:10.1016/j.autneu.2014.11.006 · Cited by 61
López-Jaramillo, P. A., Herrera, E., Garcia, R. G., Camacho, P. A., & Castillo, V. R. (2008) · American Journal of Hypertension · doi:10.1038/ajh.2007.86 · Cited by 60
Cardiovascular risk and adrenergic overdrive in the metabolic syndrome
Grassi, G. M., Quarti‐Trevano, F., Seravalle, G., & Dell’Oro, R. (2007) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.01.004 · Cited by 61
Adipose afferent reflex: sympathetic activation and obesity hypertension
Xiong, X., Chen, W., & Zhu, G. (2013) · Acta Physiologica · doi:10.1111/apha.12182 · Cited by 60
Noronha, S. I. S. R., Lima, P. M. A., Campos, G. S. V., Chírico, M. T. T., de Abreu, A. R. R., Figueiredo, A. B., Silva, F. C. S., Chianca, D. A., Lowry, C. A., & de Menezes, R. C. A. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.04.030 · Cited by 64
Asferg, C. L., Nielsen, S. J., Andersen, U. B., Linneberg, A., Møller, D. V., Hedley, P. L., Christiansen, M., Goetze, J. P., Esler, M., & Jeppesen, J. L. (2013) · Hypertension · doi:10.1161/hypertensionaha.111.00791 · Cited by 58
Self-citationDevelopmental origins of obesity‐related hypertension
Henry, S. L., Barzel, B., Wood‐Bradley, R. J., Burke, S. L., Head, G. A., & Armitage, J. A. (2011) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2011.05579.x · Cited by 60
Resistance training prevents the cardiovascular changes caused by high-fat diet
Speretta, G. F. F., Silva, A. A., Vendramini, R. C., Zanesco, A., Delbin, M. A., Menani, J. V., Bassi, M., Colombari, E., & Colombari, D. S. A. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.01.011 · Cited by 58
Sympathetic Nervous System Moves Toward Center Stage in Cardiovascular Medicine
Esler, M. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.02439 · Cited by 55
Self-citationDoes pre-pregnancy BMI determine blood pressure during pregnancy? A prospective cohort study
Savitri, A. I., Zuithoff, N. P. A., Browne, J. L., Amelia, D., Baharuddin, M., Grobbee, D. E., & Uiterwaal, C. S. P. M. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011626 · Cited by 60
Beddhu, S., Nigwekar, S. U., Ma, X., & Greene, T. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp057 · Cited by 50
Fargali, S., Garcia, A. L., Sadahiro, M., Jiang, C. S., Janssen, W. G. M., Lin, W., Cogliani, V., Elste, A. M., Mortillo, S., Cero, C., et al. (2014) · The FASEB Journal · doi:10.1096/fj.13-239509 · Cited by 52
Effects of sympathetic modulation in metabolic disease
Carnagarin, R., Lambert, G. W., Kiuchi, M. G., Nolde, J. M., Matthews, V. B., Eikelis, N., Lambert, É., & Schlaich, M. P. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14217 · Cited by 52
Self-citationLeptin as a Key between Obesity and Cardiovascular Disease
Kang, K., Ok, M., & Lee, S. (2020) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes20120 · Cited by 53
Moody, D. L. B., Chang, Y., Pantesco, E. J., Darden, T. M., Lewis, T. T., Brown, C., Bromberger, J. T., & Matthews, K. A. (2018) · Annals of Behavioral Medicine · doi:10.1093/abm/kay069 · Cited by 50
Adrenal adrenoceptors in heart failure
de Lucia, C., Femminella, G. D., Gambino, G., Pagano, G., Allocca, E., eRengo, C., Silvestri, C., Leosco, D., Ferrara, N., & Rengo, G. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00246 · Cited by 49
Stocker, S. D., & Muntzel, M. S. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00173.2013 · Cited by 48
Ganguly, A., Sharma, K., & Majumder, K. (2019) · Advances in food and nutrition research · doi:10.1016/bs.afnr.2019.04.001 · Cited by 51
Metadata
- Authors
- Esler, M., Straznicky, N., Eikelis, N., Masuo, K., Lambert, G., & Lambert, E.
- Affiliations
- Baker Heart and Diabetes Institute (AU)
- From the Human Neurotransmitter Laboratory, Baker Heart Research Institute, Melbourne, Australia.
- Venue
- Hypertension
- Published
- 2006-11
- Volume
- 48
- Issue
- 5
- Pages
- 787-796
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2119686163
- Cited by
- 443
- References
- 108
- Citations by year
- 2026: 10 · 2025: 14 · 2024: 6 · 2023: 20 · 2022: 8 · 2021: 16 · 2020: 23 · 2019: 26 · 2018: 19 · 2017: 28 · 2016: 29 · 2015: 23 · 2014: 27 · 2013: 51 · 2012: 29
- FWCI
- 3.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Hypertension (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
- Keywords
- sympathetic activation, obesity, obesity-related hypertension, hypertension pathophysiology, sympathetic hyperactivity
- MeSH terms
- Animals, Disease Models, Animal, Humans, Hypertension, Hypothalamus, Obesity, Sympathetic Nervous System
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
